Global Nanomedicine Market Research Report - Segmented by Application (Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging Implants); by Indication (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Others); by Molecule Type (Nanoparticles, Nanoshells, Nanotubes, Nanodevices); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-2905
Format:
Region: Global
Chapter 1. NANOMEDICINE MARKET - Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. NANOMEDICINE MARKET - Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID-19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. NANOMEDICINE MARKET - Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier - Distributor Analysis
Chapter 4. NANOMEDICINE MARKET - Entry Scenario
4.1 Case Studies – Start-up/Thriving Companies
4.2 Regulatory Scenario - By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. NANOMEDICINE MARKET - Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. NANOMEDICINE MARKET - By Application
6.1 Therapeutics
6.2 In-vitro Diagnostics
6.3 Drug Delivery
6.4 In-vivo Imaging
6.5 Implants
Chapter 7. NANOMEDICINE MARKET - By Indication
7.1 Clinical Oncology
7.2 Infectious Diseases
7.3 Clinical Cardiology
7.4 Orthopedics
7.5 Others
Chapter 8. NANOMEDICINE MARKET - By Molecule Type
8.1 Nanoparticles
8.2 Nanoshells
8.3 Nanotubes
8.4 Nanodevices
Chapter 9. NANOMEDICINE MARKET – By Region
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Latin America
9.5 The Middle East
9.6 Africa
Chapter 10. NANOMEDICINE MARKET – Key Players
10.1 Abbott Laboratories
10.2 CombiMatrix Corporation
10.3 Celgene Corporation
10.4 Nanospectra Biosciences, Inc.
10.5 GE Healthcare
10.6 Johnson & Johnson Services, Inc.
10.7 Mallinckrodt Pharmaceuticals
10.8 Merck & Co., Inc.
10.9 Pfizer, Inc.
10.10 Teva Pharmaceutical Industries Ltd.
10.11 Arrowhead Pharmaceuticals, Inc
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The use of nanotechnology in medicine is known as nanomedicine. Nanomaterials, biological devices, nanoelectronic biosensors, and even potential future uses of molecular nanotechnology, including biological machines, are all included in the field of nanomedicine.
The Global Nanomedicine Market was estimated to be worth USD 379.40 million in 2022 and is projected to reach a value of USD 980.40 million by 2030, growing at a CAGR of 12.6% during the forecast period 2023-2030.
Increased use of nanotechnology and nanomedicine by pharmaceutical manufacturers to create new drugs in the healthcare industry and rising chronic disease prevalence are the driving factors of the Global Nanomedicine Market.
The development of the nanomedicine market may be hampered by a lack of compatibility, possible dangers, and strict regulatory requirements.
Asia-Pacific region is the fastest growing in the Global Nanomedicine Market.
